Maiko Tanaka

This generated page lists source notes whose first nav_path entry is Maiko Tanaka. It is a coverage index, not a full synthesis page.

sourcenav pathheadings
20240722_183432Maiko Tanaka > Metabolomics > MIBG > Milestones (process)Translational and early clinical research plans to (Portfolio Entry — PE); Portfolio Entry (PE); Candidate Selection (CS); High-level scientific definition/requirements for each sub-stage in NS DDU (6/21); High-Level Guideline for Activities/Deliverables in Pre-Clinical Stages; …